CLOSE
SITE MAP
イノベーションが
生まれる「まち」。

2021/08/27

International Session1:SPARK GROBAL-SPARK in the Time of COVID-19-

Daria先生.png

[SPARK in the time of COVID-19]
The title is borrows from Gabriel Garcia Marquez's novel 'Love in the time of Cholera'.

The talk included three topics:
1. About SPARK - What is SPARK? / Why do we do it? / What are our goals?
2. About SPARK Global - What is SPARK Global and why do it now?
3. About COVID - How SPARK responded to COVID-19.

Click here for the lecture content.
SPARK_Daria Mochly-Rosen.pdf

Profile

Daria Mochly-Rosen is a protein chemist in the Chemical and Systems Biology department at Stanford and leads a multi-disciplinary research lab focusing on the molecular mechanisms of diseases. She has published >280 articles and dozens of patents, was the Chair of her department (2001-2004), and the Senior Associate Dean for Research (2006-2013) at Stanford University, School of Medicine.
Dr. Mochly-Rosen founded three biotech companies, including KAI Pharmaceuticals (acquired by Amgen and KAI's product, Parasbiv, is approved). Her experience translating basic research to drug development efforts led her to found SPARK, Stanford's translational research program. Started in 2006, SPARK has a >60% success rate, which is measured by projects licensed to excising companies (13) or startups (43) and/or going straight to clinical trials (17) addressing local and global health care needs. In 2020, SPARK At Stanford won the Xconomy National Award for Ecosystem Development, as well as the Janet Davison Rowley Patient Impact Research Award from Cures Within Reach. SPARK's model has been adopted in more than 60 institutes across 22 countries, and Mochly-Rosen serves as President and Founder of the SPARK GLOBAL organization.